Given Halberd News Today

Halberd (OTCMKTS:HALB – Get Free Report) is one of 385 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Halberd to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Valuation & Earnings This table compares […]

Halberd (OTCMKTS:HALB – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to similar companies based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, earnings and risk. Profitability This table compares Halberd and its peers’ net […]

Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings. Insider & Institutional Ownership 22.1% of shares of all […]

Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends. Institutional and Insider Ownership 22.1% of shares […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, profitability, valuation, risk, earnings, dividends and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its profitability, earnings, risk, analyst recommendations, dividends, valuation and institutional ownership. Earnings and Valuation This table compares Halberd […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 371 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, earnings, profitability and valuation. Profitability This table compares Halberd and its competitors’ net […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 344 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Valuation and Earnings This table compares Halberd and its […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 348 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, dividends and risk. Earnings & Valuation This table compares Halberd and its […]

Halberd (OTCMKTS:HALB – Get Rating) is one of 348 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to related businesses based on the strength of its dividends, risk, earnings, profitability, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 24.9% of shares of all […]